Phase I/IIA Study of SAR422459 in Participants With Stargardt’s Macular Degeneration
Estado: Terminado |
Categoría: Stargardt |
Resultado: Tiene resultados ENFERMEDAD DE STARGARDT
MEDICAMENTO: SAR422459
Investigational Site Number 840002, Miami, Florida, United States
Investigational Site Number 840005, Iowa City, Iowa, United States
Investigational Site Number 840001, Portland, Oregon, United States
Investigational Site Number 840004, Houston, Texas, United States
Investigational Site Number 250001, Paris, France
Ver informe